Oftaquix (Levofloxacin Hemihydrate)

Levofloxacin Hemihydrate, the active ingredient in Oftaquix, is a fluoroquinolone antibiotic presented as a solid oral dosage form for systemic use. It treats a variety of bacterial infections in adults and children when prescribed by a healthcare professional.

GNH USA supplies Oftaquix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oftaquix is a fluoroquinolone antibiotic that targets bacterial DNA replication pathways. It is employed in the management of several established infections: - Community‑acquired bacterial pneumonia: helps eradicate the causative pathogens and improve respiratory symptoms. - Acute bacterial sinusitis: reduces sinus inflammation by eliminating the infecting bacteria. - Uncomplicated urinary tract infection: clears the urinary tract of susceptible bacteria, relieving dysuria and frequency.

Levofloxacin, like other fluoroquinolones, may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools that may be watery. - Headache: transient cranial discomfort. - Dizziness: occasional light‑headedness. - Photosensitivity: increased skin sensitivity to sunlight.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or loss of function, especially in the Achilles. - QT interval prolongation: irregular heart rhythm detectable on ECG. - Severe allergic reaction: hives, swelling, or breathing difficulty. - Peripheral neuropathy: tingling or numbness in extremities. - Clostridioides difficile colitis: severe diarrhea with abdominal pain.

Before initiating therapy with Oftaquix, consider the following safety measures: - Renal impairment: dose adjustment may be required based on kidney function. - Hepatic impairment: monitor liver enzymes during treatment. - History of tendon disorders: avoid use in patients with prior tendon injury. - Concomitant QT‑prolonging drugs: assess risk of cardiac arrhythmias. - Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Levofloxacin may interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminium or magnesium: reduce levofloxacin absorption. - Warfarin: may increase anticoagulant effect and bleeding risk. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened risk of central nervous system stimulation.

Moderate Interactions (Monitor Closely): - Theophylline: may increase serum theophylline concentrations. - Cyclosporine: potential for increased nephrotoxicity. - Oral contraceptives: possible reduction in contraceptive effectiveness.